2021 ICD-10-CM Code A69.20
Lyme disease, unspecified
Valid for Submission
A69.20 is a billable diagnosis code used to specify a medical diagnosis of lyme disease, unspecified. The code A69.20 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code A69.20 might also be used to specify conditions or terms like acute lyme disease, congenital lyme disease, disseminated lyme borreliosis, erythema chronica migrans, infection - non-suppurative , infection of skin caused by borrelia, etc.
Unspecified diagnosis codes like A69.20 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
ICD-10: | A69.20 |
Short Description: | Lyme disease, unspecified |
Long Description: | Lyme disease, unspecified |
Code Classification
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code A69.20 are found in the index:
- - Disease, diseased - See Also: Syndrome;
- - Lyme - A69.20
- - Erythema, erythematous (infectional) (inflammation) - L53.9
- - chronicum migrans (Borrelia burgdorferi) - A69.20
- - migrans - A26.0
- - chronicum - A69.20
- - Lyme disease - A69.20
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acute lyme disease
- Congenital Lyme disease
- Disseminated Lyme borreliosis
- Erythema chronica migrans
- Infection - non-suppurative
- Infection of skin caused by Borrelia
- Lyme disease
- Non-pyogenic bacterial infection of skin
Clinical Information
- POST LYME DISEASE SYNDROME-. a condition caused by long lasting and ongoing infection with the spirochete borrelia burgdorferi resulting in progressive inflammatory neurologic neuromuscular and dermatologic manifestations including encephalitis; myelitis; acrodermatitis chronica atrophicans; and arthritis.
- LYME DISEASE-. an infectious disease caused by a spirochete borrelia burgdorferi which is transmitted chiefly by ixodes dammini see ixodes and pacificus ticks in the united states and ixodes ricinis see ixodes in europe. it is a disease with early and late cutaneous manifestations plus involvement of the nervous system heart eye and joints in variable combinations. the disease was formerly known as lyme arthritis and first discovered at old lyme connecticut.
- LYME NEUROBORRELIOSIS-. nervous system infections caused by tick borne spirochetes of the borrelia burgdorferi group. the disease may affect elements of the central or peripheral nervous system in isolation or in combination. common clinical manifestations include a lymphocytic meningitis cranial neuropathy most often a facial neuropathy polyradiculopathy and a mild loss of memory and other cognitive functions. less often more extensive inflammation involving the central nervous system encephalomyelitis may occur. in the peripheral nervous system b. burgdorferi infection is associated with mononeuritis multiplex and polyradiculoneuritis. from j neurol sci 1998 jan 8;1532:182 91
- LYME DISEASE VACCINES-. vaccines or candidate vaccines used to prevent lyme disease.
- BORRELIA BURGDORFERI-. a specific species of bacteria part of the borrelia burgdorferi group whose common name is lyme disease spirochete.
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code A69.20 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
Convert A69.20 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code A69.20 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 088.81 - Lyme disease (Approximate Flag)
Information for Patients
Lyme Disease
Lyme disease is a bacterial infection you get from the bite of an infected tick. The first symptom is usually a red rash, which may look like a bull's eye. But not all people with Lyme disease have a rash. As the infection spreads to other parts of the body, you may have
- A fever
- A headache
- Body aches
- A stiff neck
- Fatigue
Lyme disease can be hard to diagnose because many of its symptoms are like those of the flu and other diseases. And you may not have noticed a tick bite. Your health care provider will look at your symptoms and medical history to figure out whether you have Lyme disease. Lab tests may not always give a clear answer until you have been infected for at least a few weeks.
Antibiotics can cure most cases of Lyme disease. The sooner treatment begins, the quicker and more complete the recovery.
After treatment, some patients may still have muscle or joint aches and nervous system symptoms. This is called post-treatment Lyme disease syndrome (PTLDS). Long-term antibiotics have not been shown to help with PTLDS. However, there are ways to help with the symptoms of PTLDS, and most patients do get better with time.
NIH: National Institute of Allergy and Infectious Diseases
- Lyme disease (Medical Encyclopedia)
- Lyme disease antibody (Medical Encyclopedia)
- Ticks and Lyme Disease: Symptoms, Treatment, and Prevention (Food and Drug Administration)
[Learn More]
Lyme disease Lyme disease is an infectious disease caused by Borrelia burgdorferi bacteria. The bacteria are transferred to humans by tick bite, specifically by blacklegged ticks (commonly known as deer ticks). The condition is named for the location in which it was first described, the town of Lyme, Connecticut.If not treated with antibiotics, Lyme disease follows three stages: early localized, early disseminated, and late disseminated infection. A small percentage of individuals have symptoms that persist months or years after treatment, which is called post-treatment Lyme disease syndrome.A characteristic feature of Lyme disease, and the key feature of early localized infection, is a slowly expanding red rash on the skin (called erythema migrans) at the site of the tick bite; the rash is often bull's-eye shaped. Flu-like symptoms and enlarged lymph nodes (lymphadenopathy) are also early signs of infection. Most people who are treated at this stage never develop further symptoms.The early disseminated stage of Lyme disease occurs as the bacteria is carried throughout the body in the bloodstream. This stage occurs a few weeks after the tick bite. Signs and symptoms can include additional rashes on other parts of the body, flu-like symptoms, and lymphadenopathy. Some affected individuals develop neurologic problems (referred to as neuroborreliosis), such as paralyzed muscles in the face (facial palsy); pain, numbness, or weakness in the hands or feet; difficulty concentrating; or memory problems. Rarely, the heart is affected (Lyme carditis), causing a sensation of fluttering or pounding in the chest (palpitations) or an irregular heartbeat.The late disseminated stage of Lyme disease can occur months to years after the tick bite. The most common feature of this stage, Lyme arthritis, is characterized by episodes of joint pain and swelling, usually affecting the knees. In rare cases, the late disseminated stage also involves neurological problems.Individuals with post-treatment Lyme disease syndrome report ongoing exhaustion (fatigue), muscle and joint achiness, headache, or difficulty concentrating even after treatment with antibiotics, when there is no evidence of the bacteria in the body. Very rarely, individuals have joint pain and swelling for months or years after successful antibiotic treatment. This complication is called antibiotic-refractory Lyme arthritis.
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)